医学
化疗
吉西他滨
肺癌
顺铂
刺激
紫杉醇
内科学
性能状态
胃肠病学
肿瘤科
麻醉
泌尿科
作者
Guohua Lin,Lizhu Lin,Ying Zhang,Wenya Pei,Jingchun Zeng,Weixuan Zhao
出处
期刊:PubMed
[National Institutes of Health]
日期:2019-02-25
卷期号:44 (2): 136-9
被引量:5
标识
DOI:10.13702/j.1000-0607.170933
摘要
OBJECTIVE: To observe the influence of fire needle stimulation at Sihua acupoints combined with chemotherapy on Th1/Th2 imbalance and performance status in the patients with advanced non-small cell lung cancer (NSCLC) so as to investigate its immunological mechanism underlying the improvement of lung cancer. METHODS: =30 cases in each one). The control group was treated with paclitaxel combined with cisplatin (TP) or gemcitabine plus cisplatin (GP) of chemotherapy, and the treatment group was treated with fire needle stimulation at Sihua acupoints (i.e. bilateral Geshu [BL17] and Danshu [BL19]) and with chemotherapy simultaneously. The fire needle stimulation was given once daily for successive 7 days. One day before and 14 days after chemotherapy, the patients' blood samples were collected for assaying the concentrations of Th1 related cytokines (IL-2, IFN-γ) and Th2 related cytokines (IL-4, IL-10) with ELISA. The Karnofsky performance status (KPS) score was used to assess the patient's physical conditions before and 14 days after chemotherapy. RESULTS: <0.01). CONCLUSION: Fire needle stimulation at Sihua acupoints improves the function of Th1 cells, and reduces the function of Th2 cells. As a result, the balance between Th1 and Th2 has been modified and the deterioration degree of the performance status been alleviated in the patients after chemotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI